TATACONSUM — Tata Consumer developing products to address side effects of GLP-1 weight-loss drugs

Tata Consumer Products is strategically developing a new line of nutritional products aimed at managing the side effects associated with GLP-1 weight-loss medications. The move signals the company's entry into the health and wellness space supporting pharmaceutical therapies. This initiative seeks to capitalize on the rapidly growing global market for obesity treatments.